| 27220399 | HMGB1 knockdown effectively inhibits the progression of rectal cancer by suppressing HMGB1 expression and promoting apoptosis of rectal cancer cells. | Mol Med Rep | 2016 Jul | Wang Z | doi: 10.3892/mmr.2016.5340 |
| 23723299 | HMGB1 in cancer: good, bad, or both? | Clin Cancer Res | 2013 Aug 1 | Kang R | doi: 10.1158/1078-0432.CCR-13-0495 |
| 25986235 | Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer. | J Exp Clin Cancer Res | 2015 May 20 | Zhang Z | doi: 10.1186/s13046-015-0166-1. |
| 23467607 | Overexpression of high mobility group protein B1 correlates with the proliferation and metastasis of lung adenocarcinoma cells. | Mol Med Rep | 2013 May | Sun KK | doi: 10.3892/mmr.2013.1362 |
| 26952810 | Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis. | Cancer Lett | 2016 Jun 1 | Lv W | doi: 10.1016/j.canlet.2016.02.005 |
| 24146279 | HMGB1 combining with tumor-associated macrophages enhanced lymphangiogenesis in human epithelial ovarian cancer. | Tumour Biol | 2014 Mar | Zhang W | doi: 10.1007/s13277-013-1288-8 |
| 26922571 | Cytoplasmic expression of high mobility group B1 (HMGB1) is associated with tumor-infiltrating lymphocytes (TILs) in breast cancer. | Pathol Int | 2016 Apr | Lee HJ | doi: 10.1111/pin.12393 |
| 19445369 | [Immunological aspects of anticancer chemotherapy]. | Bull Acad Natl Med | 2008 Oct | Zitvogel L | - |
| 24681824 | The role of high mobility group box 1 (HMGB1) in colorectal cancer. | Med Sci Monit | 2014 Mar 31 | S??ren D | doi: 10.12659/MSM.890531. |
| 23318458 | The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics. | Oncogene | 2014 Jan 30 | Kang R | doi: 10.1038/onc.2012.631 |
| 26617792 | MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma. | Int J Clin Exp Pathol | 2015 Sep 1 | Xiao P | - |
| 22747650 | High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy. | J Transl Med | 2012 Jul 2 | Liu F | doi: 10.1186/1479-5876-10-135. |
| 25639284 | HMGB1 genetic polymorphisms in oral squamous cell carcinoma and oral lichen planus patients. | Oral Dis | 2015 May | Supic G | doi: 10.1111/odi.12318 |
| 24213571 | High mobility group box 1 promotes tumor cell migration through epigenetic silencing of semaphorin 3A. | Oncogene | 2014 Oct 30 | Nehil M | doi: 10.1038/onc.2013.459 |
| 22105604 | Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). | Mol Med | 2012 Mar 30 | Yang H | doi: 10.2119/molmed.2011.00389. |
| 21181308 | HMGB1 promotes lymphangiogenesis of human lymphatic endothelial cells in vitro. | Med Oncol | 2012 Mar | Qiu Y | doi: 10.1007/s12032-010-9778-7 |
| 15201494 | Effects of HMGB-1 overexpression on cell-cycle progression in MCF-7 cells. | J Korean Med Sci | 2004 Jun | Yoon S | - |
| 20622903 | HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. | Oncogene | 2010 Sep 23 | Tang D | doi: 10.1038/onc.2010.261 |
| 21120500 | Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-α and TNF-α in systemic lupus erythematosus. | Rheumatol Int | 2012 Feb | Ma CY | doi: 10.1007/s00296-010-1636-6 |
| 26106610 | HMGB1-Induced Cross Talk between PTEN and miRs 221/222 in Thyroid Cancer. | Biomed Res Int | 2015 | Mardente S | doi: 10.1155/2015/512027 |
| 21642542 | Knockdown of HMGB1 in tumor cells attenuates their ability to induce regulatory T cells and uncovers naturally acquired CD8 T cell-dependent antitumor immunity. | J Immunol | 2011 Jul 1 | Liu Z | doi: 10.4049/jimmunol.1003378 |
| 24481712 | Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-??B pathway in vitro and in vivo. | Int J Oncol | 2014 Apr | Zhang J | doi: 10.3892/ijo.2014.2285 |
| 23836405 | Invasion potential of H22 hepatocarcinoma cells is increased by HMGB1-induced tumor NF-??B signaling via initiation of HSP70. | Oncol Rep | 2013 Sep | Gong W | doi: 10.3892/or.2013.2595 |
| 23042506 | Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo. | Oncol Rep | 2013 Jan | Dong YD | doi: 10.3892/or.2012.2070 |
| 22842346 | Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. | Nat Immunol | 2012 Sep | Chiba S | doi: 10.1038/ni.2376 |
| 24078503 | Cytosolic HMGB1 expression in human renal clear cell cancer indicates higher pathological T classifications and tumor grades. | Urol J | 2013 Sep 26 | Takeuchi T | - |
| 22265157 | HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer. | Oral Oncol | 2012 May | Wild CA | doi: 10.1016/j.oraloncology.2011.12.009 |
| 27769864 | HMGB1 induces human non-small cell lung cancer cell motility by activating integrin αvβ3/FAK through TLR4/NF-??B signaling pathway. | Biochem Biophys Res Commun | 2016 Nov 25 | Zhu J | doi: 10.1016/j.bbrc.2016.10.052 |
| 28216372 | Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis. | Cancer Lett | 2017 May 28 | Chen S | doi: 10.1016/j.canlet.2017.02.011 |
| 28574630 | High-mobility group box-1 contributes tumor angiogenesis under interleukin-8 mediation during gastric cancer progression. | Cancer Sci | 2017 Aug | Chung HW | doi: 10.1111/cas.13288 |
| 27262996 | Pivotal role of high-mobility group box 1 (HMGB1) signaling pathways in glioma development and progression. | J Mol Med (Berl) | 2016 Aug | Angelopoulou E | doi: 10.1007/s00109-016-1435-y |
| 29848691 | Clinical Implication of the Relationship Between High Mobility Group Box-1 and Tumor Differentiation in Hepatocellular Carcinoma. | Anticancer Res | 2018 Jun | Ando K | doi: 10.21873/anticanres.12609. |
| 29679570 | HMGB1-containing nucleosome mediates chemotherapy-induced metastasis of human lung cancer. | Biochem Biophys Res Commun | 2018 Jun 7 | Wang K | doi: 10.1016/j.bbrc.2018.04.150 |
| 29562957 | miR-449a Suppresses Tumor Growth, Migration, and Invasion in Non-Small Cell Lung Cancer by Targeting a HMGB1-Mediated NF-??B Signaling Pathway. | Oncol Res | 2019 Feb 5 | Wu D | doi: 10.3727/096504018X15213089759999 |
| 30375073 | HMGB1 knock-down promoting tumor cells viability and arrest pro-apoptotic proteins via Stat3/NF??B in HepG2 cells. | Biofactors | 2018 Nov | Alduais S | doi: 10.1002/biof.1456 |
| 20846416 | Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer. | BMC Cancer | 2010 Sep 16 | Peng RQ | doi: 10.1186/1471-2407-10-496. |
| 19571604 | Suppression of dendritic cells by HMGB1 is associated with lymph node metastasis of human colon cancer. | Pathobiology | 2009 | Kusume A | doi: 10.1159/000218331 |
| 26720492 | mir-129-5p Attenuates Irradiation-Induced Autophagy and Decreases Radioresistance of Breast Cancer Cells by Targeting HMGB1. | Med Sci Monit | 2015 Dec 31 | Luo J | - |
| 19148477 | Short hairpin RNA (shRNA) constructs targeting high mobility group box-1 (HMGB1) expression leads to inhibition of prostate cancer cell survival and apoptosis. | Int J Oncol | 2009 Feb | Gnanasekar M | - |
| 25277185 | High mobility group Box-1 inhibits cancer cell motility and metastasis by suppressing activation of transcription factor CREB and nWASP expression. | Oncotarget | 2014 Sep 15 | Zuo Z | - |
| 27049097 | Changes of HMGB1 expression on angiogenesis of ovarian cancer and its mechanism. | J Biol Regul Homeost Agents | 2016 Jan-Mar | Zhou LY | - |
| 27829233 | MiR-142 inhibits the development of cervical cancer by targeting HMGB1. | Oncotarget | 2017 Jan 17 | Jiang D | doi: 10.18632/oncotarget.13136. |
| 29355524 | Long non-coding RNA UCA1 promotes lung cancer cell proliferation and migration via microRNA-193a/HMGB1 axis. | Biochem Biophys Res Commun | 2018 Feb 5 | Wu H | doi: 10.1016/j.bbrc.2018.01.097 |
| 27391431 | HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review. | Oncotarget | 2016 Aug 2 | Wu T | doi: 10.18632/oncotarget.10413. |
| 29104475 | Association of HMGB1 Gene Polymorphisms with Lung Cancer Susceptibility and Clinical Aspects. | Int J Med Sci | 2017 Sep 19 | Hu W | doi: 10.7150/ijms.20933 |
| 29845254 | High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-??B signaling pathway. | Int J Oncol | 2018 Aug | Zhang J | doi: 10.3892/ijo.2018.4420 |
| 30257412 | MiR-1284 enhances sensitivity of cervical cancer cells to cisplatin via downregulating HMGB1. | Biomed Pharmacother | 2018 Nov | Chen J | doi: 10.1016/j.biopha.2018.08.059 |
| 22750245 | High mobility group box-1 is phosphorylated by protein kinase C zeta and secreted in colon cancer cells. | Biochem Biophys Res Commun | 2012 Jul 27 | Lee H | doi: 10.1016/j.bbrc.2012.06.116 |
| 26305032 | Clinical impact of high mobility group box 1 protein in epithelial ovarian cancer. | Arch Gynecol Obstet | 2016 Mar | Paek J | doi: 10.1007/s00404-015-3864-1 |
| 24965109 | High Mobility Group Box1 (HMGB1) released from cancer cells induces the expression of pro-inflammatory cytokines in peritoneal fibroblasts. | Pathol Int | 2014 Jun | Abe A | doi: 10.1111/pin.12167. |
| 20430742 | Serum levels of HMGB1, survivin, and VEGF in patients with advanced non-small cell lung cancer during chemotherapy. | Folia Histochem Cytobiol | 2009 | Naumnik W | doi: 10.2478/v10042-009-0025-z. |
| 22237993 | Increased expression of HMGB1 is associated with poor prognosis in human bladder cancer. | J Surg Oncol | 2012 Jul 1 | Yang GL | doi: 10.1002/jso.23040 |
| 19476625 | Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer. | J Transl Med | 2009 May 28 | Chung HW | doi: 10.1186/1479-5876-7-38. |
| 19639200 | The expression of high-mobility group protein box 1 correlates with the progression of non-small cell lung cancer. | Oncol Rep | 2009 Sep | Shen X | - |
| 24705787 | Expression of RAGE and HMGB1 in thymic epithelial tumors, thymic hyperplasia and regular thymic morphology. | PLoS One | 2014 Apr 4 | Moser B | doi: 10.1371/journal.pone.0094118 |
| 25872129 | The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow. | Pancreas | 2015 May | Shakir M | doi: 10.1097/MPA.0000000000000298. |
| 23866030 | Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients. | World J Surg Oncol | 2013 Jul 18 | He W | doi: 10.1186/1477-7819-11-161. |
| 26896489 | The repair capacity of lung cancer cell lines A549 and H1299 depends on HMGB1 expression level and the p53 status. | J Biochem | 2016 Jul | Yusein-Myashkova S | doi: 10.1093/jb/mvw012 |
| 21953494 | Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC-803 gastric cancer cells. | Cell Biochem Funct | 2012 Jan | Song B | doi: 10.1002/cbf.1811 |
| 20812762 | Analysis of nuclear high mobility group box 1 (HMGB1)-binding proteins in colon cancer cells: clustering with proteins involved in secretion and extranuclear function. | J Proteome Res | 2010 Sep 3 | Lee H | doi: 10.1021/pr100386r. |
| 22108005 | Autophagy-mediated HMGB1 release antagonizes apoptosis of gastric cancer cells induced by vincristine via transcriptional regulation of Mcl-1. | Autophagy | 2012 Jan | Zhan Z | doi: 10.4161/auto.8.1.18319 |
| 20193282 | [Effects of high mobility group box-1 silencing upon the invasion and proliferation in human lung cancer cell L9981 by RNA inhibition]. | Zhonghua Yi Xue Za Zhi | 2009 Dec 1 | Zhang P | - |
| 26001393 | High-mobility group box 1 protein activating nuclear factor-??B to upregulate vascular endothelial growth factor C is involved in lymphangiogenesis and lymphatic node metastasis in colon cancer. | J Int Med Res | 2015 Aug | Li Y | doi: 10.1177/0300060515581671 |
| 24710933 | miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1. | J Huazhong Univ Sci Technolog Med Sci | 2014 Apr | Chang BP | doi: 10.1007/s11596-014-1259-3 |
| 25572734 | Clinical significance of hmgb1 expression in human gastric cancer. | Int J Immunopathol Pharmacol | 2014 Oct-Dec | Zhang J | - |
| 25776482 | Expression of MicroRNA-325-3p and its potential functions by targeting HMGB1 in non-small cell lung cancer. | Biomed Pharmacother | 2015 Mar | Yao S | doi: 10.1016/j.biopha.2015.01.013 |
| 26719575 | The Role of HMGB1 in Radioresistance of Bladder Cancer. | Mol Cancer Ther | 2016 Mar | Shrivastava S | doi: 10.1158/1535-7163.MCT-15-0581 |
| 20123075 | High-mobility group box 1 and cancer. | Biochim Biophys Acta | 2010 Jan-Feb | Tang D | doi: 10.1016/j.bbagrm.2009.11.014. |
| 25622595 | Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study. | World J Surg Oncol | 2015 Jan 27 | Hongo K | doi: 10.1186/1477-7819-13-7. |
| 17504981 | Masquerader: high mobility group box-1 and cancer. | Clin Cancer Res | 2007 May 15 | Ellerman JE | - |
| 22983919 | Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy. | Tumour Biol | 2013 Feb | Stoetzer OJ | doi: 10.1007/s13277-012-0513-1 |
| 26261503 | Expression of HMGB1/RAGE protein in renal carcinoma and its clinical significance. | Int J Clin Exp Pathol | 2015 Jun 1 | Qie GQ | - |
| 27383136 | HMGB1 Enhances Drug Resistance and Promotes In Vivo Tumor Growth of Lung Cancer Cells. | DNA Cell Biol | 2016 Oct | Zheng H | - |
| 20185963 | HMGB1 attenuates anti-metastatic defense of the lymph nodes in colorectal cancer. | Pathobiology | 2010 | Moriwaka Y | doi: 10.1159/000272950 |
| 15666359 | Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development. | Prostate | 2005 Jun 15 | Ishiguro H | - |
| 26948869 | The HMGB1 protein induces a metabolic type of tumour cell death by blocking aerobic respiration. | Nat Commun | 2016 Mar 7 | Gdynia G | doi: 10.1038/ncomms10764. |
| 16951227 | DNA repair pathway profiling and microsatellite instability in colorectal cancer. | Clin Cancer Res | 2006 Sep 1 | Yu J | - |
| 23175347 | [HMGB1--its role in tumor progression and anticancer therapy]. | Postepy Hig Med Dosw (Online) | 2012 Nov 22 | Smolarczyk R | doi: 10.5604/17322693.1021108. |
| 25652880 | Autophagy-mediated HMGB1 release promotes gastric cancer cell survival via RAGE activation of extracellular signal-regulated kinases 1/2. | Oncol Rep | 2015 Apr | Zhang QY | doi: 10.3892/or.2015.3782 |
| 23023232 | HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells. | Oncol Rep | 2012 Dec | Mardente S | doi: 10.3892/or.2012.2058 |
| 14534709 | Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer. | Oncol Rep | 2003 Nov-Dec | Kuniyasu H | - |
| 26884867 | HMGB1 silence could promote MCF-7 cell apoptosis and inhibit invasion and metastasis. | Int J Clin Exp Pathol | 2015 Dec 1 | Ni P | - |
| 25684181 | Nuclear DAMP complex-mediated RAGE-dependent macrophage cell death. | Biochem Biophys Res Commun | 2015 Mar 13 | Chen R | doi: 10.1016/j.bbrc.2015.01.159 |
| 27116470 | Prognostic Significance of Tag SNP rs1045411 in HMGB1 of the Aggressive Gastric Cancer in a Chinese Population. | PLoS One | 2016 Apr 26 | Bao G | doi: 10.1371/journal.pone.0154378 |
| 25501936 | Downregulation of high mobility group box 1 modulates telomere homeostasis and increases the radiosensitivity of human breast cancer cells. | Int J Oncol | 2015 Mar | Ke S | doi: 10.3892/ijo.2014.2793 |
| 26916160 | Dichotomous Life of DNA Binding High Mobility Group Box1 Protein in Human Health and Disease. | Curr Protein Pept Sci | 2016 | Lohani N | - |
| 24998555 | Expression of high mobility group box - B1 (HMGB-1) and matrix metalloproteinase-9 (MMP-9) in non-small cell lung cancer (NSCLC). | Asian Pac J Cancer Prev | 2014 | Wang JL | - |
| 28000879 | High-mobility group box 1 is overexpressed in cervical carcinoma and promotes cell invasion and migration invitro. | Oncol Rep | 2017 Feb | Pang X | doi: 10.3892/or.2016.5317 |
| 26979829 | Mesenchymal-epithelial signalling in tumour microenvironment: role of high-mobility group Box 1. | Cell Tissue Res | 2016 Aug | Sharma S | doi: 10.1007/s00441-016-2389-7 |
| 28347236 | High mobility group box 1/toll-like receptor 4/myeloid differentiation factor 88 signaling promotes progression of gastric cancer. | Tumour Biol | 2017 Mar | Yue Y | doi: 10.1177/1010428317694312. |
| 27959427 | Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells. | Mol Med Rep | 2017 Jan | Xia J | doi: 10.3892/mmr.2016.6003 |
| 28376901 | Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression. | Radiat Oncol | 2017 Apr 4 | Jiang H | doi: 10.1186/s13014-017-0802-3. |
| 28427045 | MiR-142-3p Overexpression Increases Chemo-Sensitivity of NSCLC by Inhibiting HMGB1-Mediated Autophagy. | Cell Physiol Biochem | 2017 | Chen Y | doi: 10.1159/000467896 |
| 27241711 | Genetic predisposition of six well-defined polymorphisms in HMGB1/RAGE pathway to breast cancer in a large Han Chinese population. | J Cell Mol Med | 2016 Oct | Yue L | doi: 10.1111/jcmm.12888 |
| 27987020 | Bio-HMGB1 from breast cancer contributes to M-MDSC differentiation from bone marrow progenitor cells and facilitates conversion of monocytes into MDSC-like cells. | Cancer Immunol Immunother | 2017 Mar | Su Z | doi: 10.1007/s00262-016-1942-2 |
| 27457217 | Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy. | Cancer Med | 2016 Sep | Exner R | doi: 10.1002/cam4.827 |
| 28802057 | High-mobility group box 1 released by autophagic cancer-associated fibroblasts maintains the stemness of luminal breast cancer cells. | J Pathol | 2017 Nov | Zhao XL | doi: 10.1002/path.4958 |
| 26840258 | The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer. | Oncotarget | 2016 Apr 12 | Feng A | doi: 10.18632/oncotarget.7050. |
| 27834305 | Postoperative changes in high mobility group box 1 levels after colorectal cancer surgery. | J Int Med Res | 2017 Dec | Satoh M | doi: 10.1177/0300060516665455 |
| 29725248 | HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer. | Int J Med Sci | 2018 Mar 12 | Huang BF | doi: 10.7150/ijms.23462 |
| 29730397 | High-mobility group box 1 protein (HMGB1) gene polymorphisms and cancer susceptibility: A comprehensive meta-analysis. | Clin Chim Acta | 2018 Aug | Kumari T | doi: 10.1016/j.cca.2018.04.042 |
| 29850505 | High Mobility Group Box Protein 1 Serves as a Potential Prognostic Marker of Lung Cancer and Promotes Its Invasion and Metastasis by Matrix Metalloproteinase-2 in a Nuclear Factor-??B-Dependent Manner. | Biomed Res Int | 2018 Apr 19 | Wu X | doi: 10.1155/2018/3453706 |
| 29753015 | LncRNA ZEB2-AS1 promotes pancreatic cancer cell growth and invasion through regulating the miR-204/HMGB1 axis. | Int J Biol Macromol | 2018 Sep | Gao H | doi: 10.1016/j.ijbiomac.2018.05.044 |
| 28885675 | Up-regulated HMGB1 in the pleural effusion of non-small cell lung cancer (NSCLC) patients reduces the chemosensitivity of NSCLC cells. | Tumori | 2018 Oct | Ma Y | doi: 10.5301/tj.5000656 |
| 30066846 | Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway. | Int J Oncol | 2018 Oct | Huang M | doi: 10.3892/ijo.2018.4502 |
| 29947767 | High linear energy transfer carbon-ion irradiation increases the release of the immune mediator high mobility group box 1 from human cancer cells. | J Radiat Res | 2018 Sep 1 | Onishi M | doi: 10.1093/jrr/rry049. |
| 30653121 | Increased HMGB1 expression correlates with higher expression of c-IAP2 and pERK in colorectal cancer. | Medicine (Baltimore) | 2019 Jan | Zhang W | doi: 10.1097/MD.0000000000014069. |
| 30373858 | NAC1/HMGB1 Signaling Pathway Is Associated with Epithelial-mesenchymal Transition, Invasion, and Metastasis of Lung Cancer Cell Line. | Ann Clin Lab Sci | 2018 Sep | Liu Y | - |
| 29270668 | Cytosolic high-mobility group box protein 1 (HMGB1) and/or PD-1+TILs in the tumor microenvironment may be contributing prognostic biomarkers for patients with locally advanced rectal cancer who have undergone neoadjuvant chemoradiotherapy. | Cancer Immunol Immunother | 2018 Apr | Huang CY | doi: 10.1007/s00262-017-2109-5 |
| 30569171 | Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression. | Oncol Rep | 2019 Mar | Zhang X | doi: 10.3892/or.2018.6923 |
